by EmpathiCSubstanceS | Feb 2, 2022 | Bipolar Disorder, LSD, MDMA Sassafras Molly, OCD, Pain, Psilocybin Magic Mushroom
On 5 May 1953 the novelist Aldous Huxley dissolved four-tenths of a gram of mescaline in a glass of water, drank it, then sat back and waited for the drug to take effect. Huxley consumed the drug in his California home under the direct supervision of psychiatrist...
by EmpathiCSubstanceS | Jan 14, 2022 | LSD, MDMA Sassafras Molly, Microdosing, Neuropathy, NN-Dimethyltryptamine, OCD, Pain, Parkinson's Disease
Another myth being commercialized is that psychedelic drugs will make you a peaceful, righteous human. The notion that the world’s problems would be solved if more people took entheogens is a hallucination in and of itself. However, there are countless examples of...
by EmpathiCSubstanceS | Jan 14, 2022 | Cancer, Cannabis Marijuana, Chronic Pain, Depression, LSD, Neuropathy, Pain, Psychotropics
A first-of-its-kind clinical trial has pitted a common antidepressant against psilocybin, the main psychedelic compound found in magic mushrooms. The results, recently published in the New England Journal of Medicine, are decidedly mixed with the primary depression...
by EmpathiCSubstanceS | Jan 13, 2022 | Chronic Pain, Cluster Headaches, Iboga, Kambo, Pain, Psilocybin Magic Mushroom, San Pedro Mescaline
Perhaps one of the most important psychedelic science articles published in 2021 came when psychopharmacologist Suresh Muthukumaraswamy and colleagues Anna Forsythe and Thomas Lumley called out the big elephant in the room of psychedelic clinical trials. The...
by EmpathiCSubstanceS | Jan 13, 2022 | Chronic Pain, Depression, Iboga, Kambo, LSD, MDMA Sassafras Molly, Pain, Parkinson's Disease
Perhaps one of the most important psychedelic science articles published in 2021 came when psychopharmacologist Suresh Muthukumaraswamy and colleagues Anna Forsythe and Thomas Lumley called out the big elephant in the room of psychedelic clinical trials. The...
